BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24638991)

  • 1. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
    Lim KC; Wang VW; Siddiqui FJ; Shi L; Chan ES; Oh HC; Tan SB; Chow PK
    Hepatology; 2015 Jan; 61(1):227-37. PubMed ID: 24638991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?
    Landman MP; Feurer ID; Pinson CW; Moore DE
    HPB (Oxford); 2011 Nov; 13(11):783-91. PubMed ID: 21999591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.
    Vitale A; Farinati F; Burra P; Trevisani F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Svegliati Baroni G; Virdone R; Chiaramonte M; Spolverato G; Cillo U;
    Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.
    Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM
    World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
    Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances.
    Nouso K; Tanaka H; Uematsu S; Shiraga K; Okamoto R; Onishi H; Nakamura S; Kobayashi Y; Araki Y; Aoki N; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):437-44. PubMed ID: 17683496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis.
    Chen S; Peng Z; Wei M; Liu W; Dai Z; Wang H; Mei J; Cheong M; Zhang H; Kuang M
    BMC Cancer; 2018 Apr; 18(1):392. PubMed ID: 29621988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K;
    Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.
    Llovet JM; Mas X; Aponte JJ; Fuster J; Navasa M; Christensen E; Rodés J; Bruix J
    Gut; 2002 Jan; 50(1):123-8. PubMed ID: 11772979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective.
    Sarasin FP; Majno PE; Llovet JM; Bruix J; Mentha G; Hadengue A
    Hepatology; 2001 May; 33(5):1073-9. PubMed ID: 11343234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK; Kim DG; Moon IS; Lee MD; Park JH
    J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    Suh CH; Kim KW; Park SH; Kim SY; Woo DC; Shin S; Pyo J; Shinagare AB; Ramaiya NH; Lim YS
    AJR Am J Roentgenol; 2018 Feb; 210(2):W63-W69. PubMed ID: 29091004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
    Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
    J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of antiviral treatment after resection in hepatitis B virus-related hepatocellular carcinoma patients with compensated cirrhosis.
    Xie L; Yin J; Xia R; Zhuang G
    Hepatology; 2018 Oct; 68(4):1476-1486. PubMed ID: 29633304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation.
    Ladabaum U; Cheng SL; Yao FY; Roberts JP
    Clin Transplant; 2011; 25(2):283-91. PubMed ID: 20156221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.
    Zhang P; Yang Y; Wen F; He X; Tang R; Du Z; Zhou J; Zhang J; Li Q
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):853-9. PubMed ID: 25919775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma in Singapore.
    Wai CT; Lee YM; Wang SC; Da Costa M; Isaac J; Wee A; Lim SG
    Singapore Med J; 2006 Jul; 47(7):584-7. PubMed ID: 16810428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.